The 'New formula for the eradication of HIV' is an invention by Dr Sidgi Syed Anwar Abdo Hasson and Prof Ali Abdullah Hasan al Jabri from the Department of Microbiology and Immunology, College of Medicine and Health Sciences, SQU.
The patent application for this invention was filed at the United States Patent and Trademark Office (USPTO) on August 25, 2017 and granted on April 8, 2019. The application process took almost three years. During this period, the application was examined by scientific and medical committees in and outside SQU, and also by professional examiners from USPTO.
Commenting on their work, the inventors said that this was the result of more than 16 years of continuous research work involving a wide range of medical-scientific research disciplines with many challenges and disappointments.
Both scientists have managed to invent, prepare and test a therapeutic formula using a female camel as a life factory model for the synthesis of a magic composition to treat HIV/AIDS patients with full eradication of HIV.
The therapeutic composition includes a formula that contains combination of herbal composition of Saussurea acrophila Diels
, Saussurea ceratocarpa
, and Aucklandia lappa Decne at a particular ratio and HIV-immunised camel milk 'having anti-HIV antibodies'.
The camel is immunised against different HIV coding clades by using DNA immunisation technology. The HIV-immunised camel's milk contains low molecular weight anti-HIV 'heavy chain' IgG ('hcIgG') antibodies, which are rare, small antibodies, that known to be produced by camels and some sharks fish.
These antibodies have unique features and due to their smaller size, they possess improved bioactivity when compared with traditional human IgG antibodies with a potential penetration into infected cells. An effective amount of the therapeutic composition can be administered to a patient infected with HIV, or having AIDS or for the prevention of HIV infection.
After research work involving in vitro testing such as toxicity testing using cell lines and different laboratory animals and camels, a clinical trial was performed to test the efficacy of the composition. During and after the treatment, all human AIDS patients involved in the clinical, with the presence of physicians and nurses, showed positive response with no side effects, and the symptoms of the patients were noticeably improved after few weeks of starting the treatment.
All patients regardless of their lifestyle, race, age and sex showed that their HIV/AIDS status were significantly improved and none of the cases became worse. According to the criteria of curative effect all cases were effective. Those patients who lost weight had about 10kg increase of body weight after less than three months of treatment. In the treated group, most if not all of the symptoms of the cases showed improvement after taking the invented formula. This was also associated with immune function improvement. The new formula for all cases tested was found to be very effective to suppress HIV replication as well as to eradicate the virus from the patients. This was confirmed after four months, were the treatment was ceased and patients were screened for HIV by reliable and most sensitive testings.
'The idea of using camel to produce the medicament is novel. We hope this will open new gates not only for the eradication and treatment of HIV infection but also for the eradication and prevention of infection with other viruses using the same concept. This is because the immune system of camels is well known to be much more effective than the human immune system,' said the inventors.